Skip to Content

Lacnotuzumab

https://www.medicalbillingandcodingcertification.net/web/image/product.template/261296/image_1920?unique=778ea14
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis[1][2].

3,868.40 € 3868.4 EUR 3,868.40 €

3,868.40 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days